Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Highly Potent MRI Contrast Agent Displaying Outstanding Sensitivity to Zinc Ions

MPG-Autoren
/persons/resource/persons214609

Wang,  G
Research Group MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons83784

Angelovski,  G
Research Group MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Wang, G., & Angelovski, G. (2021). Highly Potent MRI Contrast Agent Displaying Outstanding Sensitivity to Zinc Ions. Angewandte Chemie International Edition, 60(11), 5734-5738. doi:10.1002/anie.202014431.


Zitierlink: https://hdl.handle.net/21.11116/0000-0007-7563-6
Zusammenfassung
Zinc ions play an important role in numerous crucial biological processes in the human body. The ability to image the function of Zn 2+ would be a significant asset to biomedical research for monitoring various physiopathologies dependent on its fate. To this end, we developed a novel Gd 3+ chelate that can selectively recognize Zn 2+ over other abundant endogenous metal ions and alter its paramagnetic properties. More specifically, this lanthanide chelate displayed an extraordinary increase in longitudinal relaxivity ( r 1 ) of over 400% upon interaction with Zn 2+ at 7 T and 25 °C, which is the greatest r 1 enhancement observed for any of the metal ion-responsive Gd-based complexes at high magnetic field. A "turn-on" mechanism responsible for these massive changes was confirmed through NMR and luminescence lifetime studies on a 13 C-labeled Eu 3+ analogue. This molecular platform represents a new momentum in developing highly suitable magnetic resonance imaging contrast agents for functional molecular imaging studies of Zn 2+ .